EMEA-001750-PIP01-15-M04

Table of contents

Key facts

Invented name
Juluca
Active substance
  • rilpivirine
  • dolutegravir
Therapeutic area
Infectious diseases
Decision number
P/0209/2021
PIP number
EMEA-001750-PIP01-15-M04
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
ViiV Healthcare UK Limited

E-mail: eu.paediatric-plans@gsk.com
Tel: +1 4388998201

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating